Pilot Intervention With Near Infrared Stimulation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 104
Summary
- Conditions
- Aging
- Parkinson Disease
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This is a blinded parallel group sham controlled pilot trial, with half the participants in each group randomized to the real NIR treatment and half to the sham treatment condition.Masking: Triple (Participant, Care Provider, Outcomes Assessor)Masking Description: Research assistants who administer pre and post measures will be masked, as well as participants who receive the intervention.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 65 years and 89 years
- Gender
- Both males and females
Description
This is a pilot study of the efficacy of NIR stimulation for enhancing cognition and mood in nondemented older adults including individuals with Parkinson disease. Prior research suggests that NIR exposure may be neuroprotective and increases energy available to neurons. The current study will test ...
This is a pilot study of the efficacy of NIR stimulation for enhancing cognition and mood in nondemented older adults including individuals with Parkinson disease. Prior research suggests that NIR exposure may be neuroprotective and increases energy available to neurons. The current study will test whether age-related cognitive and mood changes in older adults and those with Parkinson disease will be affected by near infrared (NIR) stimulation. The study team will randomize older adults and those with Parkinson disease into treatment groups and evaluate neuroimaging and cognitive outcome measures, before and after an 12-week intervention involving transcranial and intranasal NIR. The protocol will involve both " lab" and " home-based" NIR stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will result in better cognitive and mood performance.
Tracking Information
- NCT #
- NCT03551392
- Collaborators
- McKnight Brain Research Foundation
- University of Arizona
- Investigators
- Principal Investigator: Dawn Bowers, Ph.D. University of Florida Principal Investigator: Adam Woods, Ph.D. University of Florida Principal Investigator: Gene Alexander, Ph.D. University of Arizona
Get Well Soon